Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Neuropharmacology

Background:

• Understanding solid lipid nanoparticle (SLN) interactions with cell membranes is crucial for effective drug delivery.
• Idebenone (IDE), an antioxidant, shows promise for neurodegenerative diseases, but its blood-brain barrier (BBB) penetration mechanism is unclear.
• SLN offer a potential carrier system to improve IDE delivery and efficacy.

Purpose of the Study:

• To investigate the interaction between unloaded/IDE-loaded SLN and biomembrane models (multilamellar vesicles).
• To evaluate the ability of SLN to facilitate IDE penetration into lipid bilayers.
• To assess the potential of SLN as a drug delivery system for IDE.

Main Methods:

• Utilized differential scanning calorimetry (DSC) to analyze SLN-biomembrane interactions.
• Incubated dimyristoylphosphatidylcholine multilamellar vesicles (MLV) with unloaded and IDE-loaded SLN.
• Monitored changes in calorimetric curves to quantify interactions and IDE release.

Main Results:

• SLN were observed to penetrate phospholipid bilayers, initially localizing in outer layers and migrating inward with increased contact time.
• IDE-loaded SLN successfully released IDE into the biomembrane model, enhancing IDE penetration.
• Free IDE demonstrated limited interaction with the biomembrane model compared to SLN-encapsulated IDE.

Conclusions:

• SLN facilitate the penetration of idebenone into biomembrane models.
• The findings suggest SLN are a promising system for improving IDE bioavailability and antioxidant activity.
• SLN-based delivery could enhance therapeutic outcomes for neurodegenerative conditions requiring IDE treatment.